Showing results (601-610 of 671) with videos related to

Sort By:
Pageof 68
Scientific Reports|December 5, 2018
Anomalous material-dependent transport of focused, laser-driven proton beamsJ Kim, C McGuffey, D C Gautier, et al.
Cancer Research|June 24, 2015
CASC15-S Is a Tumor Suppressor lncRNA at the 6p22 Neuroblastoma Susceptibility LocusMike R Russell, Annalise Penikis, Derek A Oldridge, et al.
Plos One|October 23, 2013
Massively parallel sequencing reveals an accumulation of de novo mutations and an activating mutation of LPAR1 in a patient with metastatic neuroblastomaJun S Wei, Peter Johansson, Li Chen, et al.
Oncogene|April 25, 2012
Lenalidomide promotes p53 degradation by inhibiting MDM2 auto-ubiquitination in myelodysplastic syndrome with chromosome 5q deletionS Wei, X Chen, K McGraw, et al.
Genome Research|August 16, 2020
Somatic structural variation targets neurodevelopmental genes and identifies <i>SHANK2</i> as a tumor suppressor in neuroblastomaGonzalo Lopez, Karina L Conkrite, Miriam Doepner, et al.
Cancer Research|January 11, 2007
Credentialing preclinical pediatric xenograft models using gene expression and tissue microarray analysisCraig C Whiteford, Sven Bilke, Braden T Greer, et al.
Cancers|December 10, 2021
Tumor Mutation Burden, Expressed Neoantigens and the Immune Microenvironment in Diffuse GliomasGuangyang Yu, Ying Pang, Mythili Merchant, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2020
Outcome-Related Signatures Identified by Whole Transcriptome Sequencing of Resectable Stage III/IV Melanoma Evaluated after Starting Hu14.18-IL2Richard K Yang, Igor B Kuznetsov, Erik A Ranheim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 23, 2018
Clinically Relevant Cytotoxic Immune Cell Signatures and Clonal Expansion of T-Cell Receptors in High-Risk <i>MYCN</i>-Not-Amplified Human NeuroblastomaJun S Wei, Igor B Kuznetsov, Shile Zhang, et al.
Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]|March 6, 2026
[Guidance for the use of prophylactic monoclonal antibodies against respiratory syncytial virus in primary care]S Q Wang, L Wang, Y Q Tong, et al.
Pageof 68